
Our Mission
Unlocking the Potential of iPSCs for Next-Generation Therapeutics
Induced pluripotent stem cells (iPSCs) hold the extraordinary ability to transform into any cell type in the human body, unlocking endless possibilities for innovation in medicine. At Celogics, we are dedicated to leveraging this transformative potential to become a leading force in precise iPSC differentiation, driving advancements in research and therapeutics.


Our Vision is to establish Celogics as a trusted, high-quality provider of iPSC-derived cells within the pharmaceutical and research communities.
Celogics is committed Excellence and Innovation. We prioritize rigorous quality standards and innovative product formats, setting new benchmarks in iPSC differentiation technology.
Our product offerings are focused on research-use-only iPSC-derived cell products, under our Celo.Cells brand. These cell products are used in drug discovery, drug safety screening and disease modeling.